Langley, J. M., MacDonald, L. D., Weir, G. M., MacKinnon-Cameron, D., Ye, L., McNeil, S., . . . Halperin, S. A. (2018). A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study. J Infect Dis.
Citación estilo ChicagoLangley, Joanne M., et al. "A Respiratory Syncytial Virus Vaccine Based On the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study." J Infect Dis 2018.
Cita MLALangley, Joanne M., et al. "A Respiratory Syncytial Virus Vaccine Based On the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study." J Infect Dis 2018.